FULC NASDAQ
Fulcrum Therapeutics, Inc.
1W: -7.3%
1M: -15.0%
3M: -40.1%
YTD: -39.6%
1Y: +1.2%
3Y: +73.4%
5Y: -33.0%
$6.57
-0.02 (-0.30%)
Weekly Expected Move ±7.1%
$6
$6
$7
$7
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-76M
Net Income
-14824.7% YoY
$-64M
Free Cash Flow
-945.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-25.7%
ROA-24.3%
ROIC-2179.7%
Valuation
P/E-6.6
P/B1.5
EV/EBITDA-3.1
Leverage
Debt/Equity0.02
Current Ratio27.40
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z18.43
Beneish M0.00